BAMCO INC /NY/

Position in GILD — Gilead Sciences, Inc.

CIK 1017918 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,274,120

-$1,906,980 QoQ

Shares Held

18,000

-40.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#796

of 2,266 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

BAMCO INC /NY/ holds $189,132,430 across 5 Drug Manufacturers - General names. GILD ranks #5 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	140,540	$168,567,906
2	AZN	Astrazeneca PLC	47,835	$9,070,472
3	JNJ	Johnson & Johnson	25,172	$6,392,932
4	MRK	Merck & Co., Inc.	22,000	$2,827,000
5	GILD	Gilead Sciences, Inc. This page	18,000	$2,274,120

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,274,120	18,000	-40.0%	Shares	Defined	2026-08-14
2026-03-31	$4,181,100	30,000	+13.2%	Shares	Defined	2026-05-15
2025-12-31	$3,252,610	26,500	+10.4%	Shares	Defined	2026-02-17
2025-09-30	$2,664,000	24,000	+29.7%	Shares	Defined	2025-11-14
2025-06-30	$2,051,095	18,500	+131.2%	Shares	Defined	2025-08-14
2025-03-31	$896,400	8,000	—	Shares	Defined	2025-05-15
No filing history on record for this holder in this stock.